Related Experiment Video
Updated: Feb 2, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
CARD-BCL-10-MALT1 signalling in protective and pathological immunity
1Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany. j.ruland@tum.de.
Insights
CARD protein-BCL-10-MALT1 (CBM) signalosomes regulate immune responses by forming filaments that control inflammatory gene expression. Dysregulation of CBM signaling is linked to immune diseases and cancers.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- CARD protein-BCL-10-MALT1 (CBM) signalosomes are crucial multiprotein platforms controlling immune and inflammatory pathways.
- These complexes are essential for host defense and maintaining tissue homeostasis.
- Genetic alterations in CBM signaling components are implicated in various immune-mediated diseases.
Purpose of the Study:
- To review the regulation and signaling mechanisms of CBM complexes.
- To discuss the physiological roles of CBM signaling in host defense and homeostasis.
- To explore the pathophysiological functions of CBM complexes in immune-related diseases and cancers.
Main Methods:
- Literature review of CBM signalosome function.
- Analysis of CBM complex assembly and protease activity.
- Examination of CBM signaling in immune and inflammatory contexts.
Main Results:
- CBM signalosomes form self-organizing filaments upon immune activation.
- CBM complexes regulate canonical nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways.
- Two layers of inflammatory gene expression control are mediated by CBM signaling, including mRNA-binding protein degradation.
Conclusions:
- CBM signalosomes play a vital role in immune regulation and tissue homeostasis.
- Understanding CBM signaling is critical for addressing immune deficiencies, inflammatory disorders, and lymphoid malignancies.
- Further research into CBM complexes may reveal therapeutic targets for immune-mediated diseases.
Abstract:
CARD protein-BCL-10-MALT1 (CBM) signalosomes are multiprotein signalling platforms that control immune and inflammatory pathways in most tissues. After exposure to distinct immune triggers, these molecules form self-organizing filaments with MALT1 protease activity to regulate canonical nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signalling pathways and the degradation of mRNA-binding proteins, which provides two layers of control of inflammatory gene expression. These CBM-regulated mechanisms are essential for host defence and tissue homeostasis, and numerous genetic alterations in CBM signalling components have been implicated in inherited and acquired immune-mediated diseases. This Review discusses the regulation and signalling of CBM complexes, their physiological roles and their pathophysiological functions in human immunodeficiency diseases, inflammatory disorders and cancers of the immune system.
Related Concept Videos
What is the Immune System?
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Radial System Protection
In a radial system with a fault downstream of the third breaker, ideally, only the third breaker will open, isolating the fault and interrupting the load connected beyond it. The second breaker has a longer delay setting,...
Protecting Self-Esteem
Humoral Immune Responses

